Cellular levels of GCNF expression were higher in prostate cancer compared with normal prostate and further increased in metastatic lesions and CRPC [145], suggesting an oncogenic role of GCNF via an unknown mechanism. The gene discussed is NR6A1; the disease is Familial prostate cancer.